05 Jun 2019

CVS still defending the Aetna merger deal 

CVS Health is making the case for its merger with Aetna to two very different audiences beginning June 3. CVS held its annual investor day and issued a long-term strategic plan to “accelerate growth” ahead of the day’s proceedings, aimed at nervous investors concerned about its recent financial performance post-merger. CVS warned that it

0
09 May 2019

Government policy shift prompts Medtronic to bail on bundled knees; Responsive Orthopedics for sale

After three years in the bundled joint replacement business, a federal policy shift is prompting Medtronic to put its Responsive Orthopedics business on the auction block. The May 2016 acquisition of Minneapolis-based Responsive for an undisclosed amount put Medtronic in line for a bundled joint replacement program piloted by the Centers for Medicare & Medicaid Services. The 5-year “Comprehensive

0
27 Apr 2019

Medical Researchers Seek Sage Advice Of Elders On Aging Issue

Rachel O’Conor booted up her slides and began posing questions to six older adults sitting around a table: How should primary care physicians support patients and caregivers after a diagnosis of dementia? And what stands in the way of getting adequate support? “Please speak louder and go slower,” suggested Susanne

0
23 Apr 2019

PELVIC VEIN OBSTRUCTION: VeinCare Centers of Tennessee now implant new BD Venovo stents to open pelvis vein

  VeinCare Centers of Tennessee is one of the first clinics in the United States to implant the new BD Venovo stent in obstructed pelvic veins. The Venovo stent is the first stent designed specifically for use in treating obstruction of veins to be approved by the Food and Drug

0
22 Apr 2019

HHS TO DELIVER VALUE-BASED TRANSFORMATION IN PRIMARY CARE

The U.S. Department of Health and Human Services (HHS) Secretary Alex Azar and Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma announced the CMS Primary Cares Initiative April 22, a new set of payment models that will transform primary care to deliver better value for patients throughout the

0
13 Apr 2019

BiosupportMD dietary supplements as adjuncts in venous, lymphatic care*

  BiosupportMD is a nutraceutical company created by John Chuback, MD, FACS, RPVI, RVT, RPhS, and his business partners Christopher Tichio and Alexander von Summer in 2015. The company was the brainchild of Dr. Chuback, a board certified general and cardiovascular surgeon who has been specializing in the treatment of

0
13 Apr 2019

Healogics adds vein ablation to wound care treatments

Healogics, the nation’s largest provider of advanced chronic wound care services, announced in March that they have added vein ablation to their in-house service offerings through a new program called Healogics VeinCare. Healogics CMO William Ennis, DO, MBA, MMM, CPE, said this program allows Healogics to provide patients with a

0
10 Apr 2019

AVINGER GETS FDA OK FOR PANTHERIS SV SMALL VESSEL ATHERECTOMY DEVICE

  The U.S. Federal Drug Administration granted Aninger’s Pantheris SV small vessel image-guided atherectomy system pre-market approval in eight months. The Pantheris SV is an extension of the Redwood City, California-based company’s lumivascular image-guided atherectomy platform, which it hopes will expand the available market for its Pantheris devices by up

0
10 Apr 2019

Teleflex gets premarket OK for biomechanical MANTA Closure

  Teleflex Inc., a global provider of medical technologies for critical care and surgery, has announced that it received premarket approval from the U.S. Food and Drug Administration for the MANTA Vascular Closure Device – the first commercially available biomechanical vascular closure device designed specifically for large bore femoral arterial

0
10 Apr 2019

SPRY HEALTH KEEPS TIGHT FOCUS WITH THE LOOP SYSTEM

  The Palo Alto, California-based company has received FDA clearance for a wearable that can remotely monitor patients with chronic diseases, such as chronic obstructive pulmonary disease (COPD), allowing the detection of early signs of deterioration before symptoms are noticeable. Spry Health’s tight focus could have significantly beneficial implications for

0